Growth Stocks To Keep An Eye On - September 25th

Key Points

• Prologis, Teledyne Technologies, and Ascendis Pharma A/S are identified as the top growth stocks to watch due to their high dollar trading volume.
• Prologis is the leading company in logistics real estate, with a presence in 19 countries and approximately 1.2 billion square feet of properties.
• Ascendis Pharma focuses on developing innovative therapies for unmet medical needs, including a treatment for growth hormone deficiency.

Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose earnings are expected to grow at an above-average rate relative to the broader market, often because they reinvest profits into expansion rather than paying dividends. Investors buy these stocks primarily for capital appreciation, accepting higher valuation multiples and potentially greater price volatility in exchange for the prospect of rapid future growth. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND